Seurat Therapeutics, Inc.
https://www.seurat-therapeutics.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Seurat Therapeutics, Inc.
Deal Watch: Genentech Inks New Collaborations With Skyhawk, Convelo
Skyhawk continues its recent spate of deal-making, using its SkyStar platform in a deal with Genentech, which also is looking into neurology with Convelo. AbbVie buys STING specialist Mavupharma, while Recordati pays Novartis $390m for Cushing’s products.
Company Information
- Industry
- Biotechnology
-
Pharmaceuticals
-
Drug Delivery
- Macromolecule
- Nasal
- Site Specific
-
Drug Delivery
-
Biotechnology
- Large Molecule
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice